kyvernatx.com (KYTX) - יחס שווי שוק לשווי בספרים

The visualized price action of Kyverna Therapeutics (KYTX) shares on the GURU.Markets platform is based on a course toward global expansion through the scaling of CAR-T developments, with the current indicator standing at 2.14. Kyverna Therapeutics is reimagining oncological methods to restore immunity in severe pathologies. Additionally, the business aims to create definitive therapies for multiple sclerosis and systemic lupus erythematosus.

Kyverna Therapeutics' status as an innovator in cell therapy for autoimmune diseases determines the current market capitalization-to-book value ratio. This coefficient compares the business's market value with its net assets, demonstrating the level of investor confidence in the company's ability to convert scientific authority into capital and effectively counter rising operating expenses.